earnings
QN
NASDAQ · QNRX
Quoin Pharmaceuticals, Ltd.
Healthcare · Biotechnology
$6.90
Down-$0.07 (-1.00%)
Updated Sep 11, 2026, 12:30 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.54M
- P/E ratio
- -0.54
- Dividend yield
- 0.00%
- 52-week range
- $3.25 – $41.80
- Volume
- 31.14K
- Avg. volume
- 656.17K
Price performance
QNRX price history
1M range · 20 trading sessions · Daily adjusted prices
QNRX closed at $6.90 after 20 trading sessions, up 14.05% for the selected period.
- Last close
- $6.90
- Period change
- +14.05%
- Period low
- $4.72
- Period high
- $7.87
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $6.84 | $7.00 | $6.58 | $6.90 | 31.14K |
| Sep 9, 2026 | $7.09 | $7.10 | $6.8437 | $6.97 | 59.39K |
| Sep 8, 2026 | $7.33 | $7.65 | $7.05 | $7.15 | 196.52K |
| Sep 4, 2026 | $7.64 | $7.6869 | $7.10 | $7.26 | 79.05K |
| Sep 3, 2026 | $6.81 | $8.00 | $6.26 | $7.87 | 439.23K |
| Sep 2, 2026 | $6.50 | $6.98 | $6.40 | $6.74 | 372.46K |
| Sep 1, 2026 | $5.90 | $6.58 | $5.75 | $6.51 | 277.61K |
| Aug 31, 2026 | $5.45 | $6.55 | $5.43 | $6.22 | 567.52K |
| Aug 28, 2026 | $7.22 | $8.25 | $5.95 | $6.12 | 31.02M |
| Aug 27, 2026 | $5.1347 | $5.18 | $4.6639 | $5.155 | 33.86K |
| Aug 26, 2026 | $5.10 | $5.33 | $5.10 | $5.18 | 9.89K |
| Aug 25, 2026 | $5.32 | $5.415 | $4.85 | $5.07 | 18.18K |
| Aug 24, 2026 | $5.395 | $6.46 | $5.329 | $5.42 | 31.32K |
| Aug 21, 2026 | $5.29 | $5.88 | $5.02 | $5.57 | 72.11K |
| Aug 20, 2026 | $4.85 | $5.225 | $4.639 | $4.99 | 8.12K |
| Aug 19, 2026 | $4.90 | $4.955 | $4.60 | $4.72 | 21.31K |
| Aug 18, 2026 | $4.97 | $5.00 | $4.749 | $4.97 | 9.71K |
| Aug 17, 2026 | $4.76 | $5.20 | $4.76 | $5.19 | 17.08K |
| Aug 14, 2026 | $5.00 | $5.30 | $4.55 | $5.09 | 64.75K |
| Aug 13, 2026 | $5.79 | $6.38 | $5.65 | $6.05 | 37.38K |
Latest QNRX news
The latest Smart Investors Daily articles mentioning QNRX.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…